Index of artpub/2017/pmc_28074446/

Blauvelt, Andrew
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders : a Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
2017
https://ddd.uab.cat/record/189135
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Blauvelt,_Andrew2022-06-29 13:32 17  
[ ]2=Efficacy_and_Safety_of_Switching_to_Ixekizumab...2022-06-29 13:32 196  
[ ]3=20172022-06-29 13:32 5  
[ ]4=1891352022-06-29 13:32 34  
[TXT]pmc_28074446.dirinfo2025-02-07 02:57 341  
[ ]pmc_28074446.du2025-02-07 02:57 33  
[TXT]pmc_28074446.dupdirs2025-02-07 02:57 0  
[TXT]pmc_28074446.dupfiles2025-02-07 02:57 0  
[TXT]pmc_28074446.errors2025-02-07 02:57 0  
[IMG]pmc_28074446.gif2025-02-07 02:57 38K 
[IMG]pmc_28074446.ico2025-02-07 02:57 12K 
[TXT]pmc_28074446.info2025-02-07 02:57 25K 
[TXT]pmc_28074446.md52025-02-07 02:57 51  
[ ]pmc_28074446.pdf2025-02-07 02:57 420K 
[TXT]pmc_28074446.sha12025-02-07 02:57 59  
[TXT]pmc_28074446.sha2562025-02-07 02:57 83  
[TXT]pmc_28074446.stats2025-02-07 02:57 282  
[TXT]pmc_28074446.txt2025-02-07 02:57 43K